Nmp4/CIZ Closes the Parathyroid Hormone Anabolic Window

Chronic degenerative diseases are increasing with the aging U.S. population. One consequence of this phenomenon is the need for long-term osteoporosis therapies. Parathyroid hormone (PTH), the only FDA-approved treatment that adds bone to the aged skeleton, loses its potency within two years of init...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Bidwell, Joseph P., Childress, Paul, Alvarez, Marta B., Hood, Mark, He, Yongzheng, Pavalko, Fredrick M., Kacena, Melissa A., Yang, Feng-Chun
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3586259/
https://ncbi.nlm.nih.gov/pubmed/23140162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados